2022/1/18
Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, et al.
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
N Engl J Med. 2021 Dec 22:NEJMoa2116846.
https://pubmed.ncbi.nlm.nih.gov/34937145/
報告人：傅苡倉

2022/1/25
Henderson A, Paterson DL, Chatfield MD, Tambyah PA, Lye DC, De PP, et al.
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study.
Clin Infect Dis. 2021 Dec 6;73(11):e3842-e3850.
https://pubmed.ncbi.nlm.nih.gov/33106863/
報告人：陳奕潔

2022/2/8
Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, et al.
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
N Engl J Med. 2021 Dec 16:NEJMoa2116044.
https://pubmed.ncbi.nlm.nih.gov/34914868/
報告人：鄭菀韻

(Associated studies published on NEJM Evidence)
Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults.
https://evidence.nejm.org/pb-assets/evidence-site/content/EVIDoa2100043.pdf
Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19.
https://evidence.nejm.org/pb-assets/evidence-site/content/EVIDoa2100044.pdf

2022/2/15
Su Y, Stern A, Karantoni E, Nawar T, Han G, Zavras P, et al.
Impact of letermovir primary Cytomegalovirus (CMV) prophylaxis on 1-year mortality after allogeneic hematopoietic cell transplantation (HCT): a retrospective cohort study.
Clin Infect Dis. 2022 Jan 3:ciab1064.
https://pubmed.ncbi.nlm.nih.gov/34979021/
報告人：凌濼傑

2022/2/22
Feuerstadt P, Louie TJ, Lashner B, Wang EEL, Diao L, Bryant JA, et al.
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.
N Engl J Med. 2022 Jan 20;386(3):220-229.
https://pubmed.ncbi.nlm.nih.gov/35045228/
報告人：洪聿琦

2022/3/8
Ziegler MJ, Babcock HH, Welbel SF, Warren DK, Trick WE, Tolomeo P, et al.
Stopping Hospital Infections with Environmental Services (SHINE): A Cluster-Randomized Trial of Intensive Monitoring Methods for Terminal Room Cleaning on Rates of Multidrug-Resistant Organisms in the Intensive Care Unit.
Clin Infect Dis. 2022 Feb 1;ciac070.
https://pubmed.ncbi.nlm.nih.gov/35100614/
報告人：黃弘睿

2022/3/15
Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al.
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-1.
N Engl J Med. 2022 Feb 16.
https://pubmed.ncbi.nlm.nih.gov/35100614/
報告人：何奕緯

2022/3/22
Falcone M, Tiseo G, Galfo V, Giordano C, Leonildi A, Marciano E, et al.
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study).
Clin Microbiol Infect. 2022 Feb;28(2):298.e1-298.e7.
https://pubmed.ncbi.nlm.nih.gov/34197935/
報告人：蔣柏緯

2022/3/29
Millon L, Caillot D, Berceanu A, Bretagne S, Lanternier F, Morio F, et al.
Evaluation of serum Mucorales PCR for the diagnosis of Mucormycoses: The MODIMUCOR prospective trial.
Clin Infect Dis. 2022 Jan 5;ciab1066. 
https://pubmed.ncbi.nlm.nih.gov/34986227/
報告人：張建林

2022/4/12
Sara Thuresson, Carl-Johan Fraenkel, Sviataslau Sasinovich, Jonathan Soldemyr, Anders Widell, Patrik Medstrand, et al.
Airborne SARS-CoV-2 in hospitals – effects of aerosol-generating procedures, HEPA-filtration units, patient viral load and physical distance.
Clinical Infectious Diseases, ciac161
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac161/6539846
報告人：盧昱佑

2022/4/19
H. Lamberink, A. Wagemakers, K.C.E. Sigaloff, R. van Houdt, N.A. de Jonge, K. van Dijk
The impact of the updated EORTC MSG criteria on the classification of hematological patients with suspected invasive pulmonary aspergillosis.
https://pubmed.ncbi.nlm.nih.gov/35248746/
Clin Microbiol Infect. 2022 Mar 3:S1198-743X(22)00103-3.
報告人：賴政謙

2022/5/3 
Sucheng Mu , Hao Xiang , Yuezhu Wang , Wei Wei , Xiangyu Long , Yi Han, et al.
The pathogens of secondary infection in septic patients share a similar genotype to those that predominate in the gut.
Crit Care. 2022 Mar 24;26(1):68.
https://pubmed.ncbi.nlm.nih.gov/35331299/
報告人：劉思妤

2022/5/10
Caitlin R Rausch, Adam J DiPippo, Ying Jiang, Courtney D DiNardo, Tapan Kadia, Abhishek Maiti, et al.
Comparison of mold active triazoles as primary antifungal prophylaxis in patients with newly diagnosed acute myeloid leukemia in the era of molecularly targeted therapies.
Clin Infect Dis. 2022 Mar 23:ciac230.
https://pubmed.ncbi.nlm.nih.gov/35325094/
報告人：簡志穎

2022/5/24
Paul B. Eckburg, Lori Muir, Ian A. Critchley, Susannah Walpole, Hanna Kwak, Anne-Marie Phelan, et al.
Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection.
N Engl J Med. 2022 Apr 7;386(14):1327-1338.
https://pubmed.ncbi.nlm.nih.gov/35388666/
報告人：蔡佳叡

2022/5/31
Ori Magen, M.D., Jacob G. Waxman, M.D., Maya Makov-Assif, M.D., Roni Vered, M.D., Dror Dicker, M.D., Miguel A. Hernán, M.D.,et al
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
N Engl J Med. 2022 Apr 28;386(17):1603-1614.
https://pubmed.ncbi.nlm.nih.gov/35417631/
報告人：吳佳儒

2022/6/7
Nathavitharana RR, Mishra H, Sullivan A, Hurwitz S, Lederer P, Meintjes J, et al.
Predicting airborne infection risk: Association between personal ambient carbon dioxide level monitoring and incidence of tuberculosis infection in South African health workers.
Clin Infect Dis. 2022 Mar 26:ciac183.
https://pubmed.ncbi.nlm.nih.gov/35348657/
報告人：謝明傑

2022/6/14
Goldberg Y, Mandel M, Bar-On YM, Bodenheimer O, Freedman LS, Ash N, Alroy-Preis S, Huppert A, Milo R.
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2.
N Engl J Med. 2022 Jun 9;386(23):2201-2212.
https://pubmed.ncbi.nlm.nih.gov/35613036/
報告人：周育德

2022/6/21
Rashidi A, Peled JU, Ebadi M, Ur Rehman T, Elhusseini H, Marcello LT, et al.
Intestinal Blautia may protect against neutropenic fever in allogeneic transplant patients by augmenting the intestinal epithelium.
Clin Infect Dis. 2022 Apr 18:ciac299.
https://pubmed.ncbi.nlm.nih.gov/35435976/
報告人：陳膺帆

2022/7/12
Rhee C, Baker MA, Tucker R, Vaidya V, Holtzman M, Seethala RR, et al.
Cluster of Burkholderia cepacia Complex Infections Associated with Extracorporeal Membrane Oxygenation Water Heater Devices.
Clin Infect Dis. 2022 Mar 10:ciac200.
https://pubmed.ncbi.nlm.nih.gov/35435976/
報告人：何治廷

2022/8/2
Altarawneh HN, Chemaitelly H, Ayoub HH, Tang P, Hasan MR, Yassine HM, et al.
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
N Engl J Med. 2022 Jul 7;387(1):21-34.
https://pubmed.ncbi.nlm.nih.gov/35704396/
報告人：魏嘉德

2022/8/2
Conrad AR, Tubach S, Cantu V, Webb LM, Stroika S, Moris S, et al.
Listeria monocytogenes Illness and Deaths Associated With Ongoing Contamination of a Multi-Regional Brand of Ice Cream Products, United States, 2010-2015.
Clin Infect Dis. 2022 Jul 7:ciac550.
https://pubmed.ncbi.nlm.nih.gov/35797187/
報告人：林賢鑫

2022/8/23
Hammarström H, Krifors A, Athlin S, Friman V, Golestani K, Hällgren A, et al.
Treatment with reduced dose trimethoprim-sulfamethoxazole is effective in mild to moderate Pneumocystis jirovecii pneumonia in patients with hematologic malignancies.
Clin Infect Dis. 2022 May 20;ciac386.
https://pubmed.ncbi.nlm.nih.gov/35594562/
報告人：談啟蘋

2022/8/30
Paret R, Le Bourgeois A, Guillerm G, Tessoulin B, Rezig S, Gastinne T, et al.
Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies: a multicentre observational study.
J Antimicrob Chemother. 2022 Jun 24;dkac190.
https://pubmed.ncbi.nlm.nih.gov/35748614/
報告人：林廷駿

2022/9/6
Maertens J, Lodewyck T, Peter Donnelly J, Chantepie S, Robin C, Blijlevens N, et al.
Empiric versus pre-emptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European organization for Research and Treatment of cancer (EORTC 65091).
Clin Infect Dis. 2022 Jul 30;ciac623. 
https://pubmed.ncbi.nlm.nih.gov/35906831/
報告人：吳沛禧

2022/9/13
Bock A, Hanson BM, Ruffin F, Parsons JB, Park LP, Sharma-Kuinkel B, et al.
Clinical and Molecular Analyses of Recurrent Gram-Negative Bloodstream Infections.
Clin Infect Dis. 2022 Aug 5;ciac638.
https://pubmed.ncbi.nlm.nih.gov/35929656/
報告人：李欣恬

2022/9/28
Wang B, Briegel J, Krueger WA, Draenert R, Jung J, Weber A, et al.
Ecological effects of selective oral decontamination on multidrug-resistance bacteria acquired in the intensive care unit: a case-control study over 5 years.
Intensive Care Med. 2022 Sep;48(9):1165-1175.
https://pubmed.ncbi.nlm.nih.gov/35953676/
報告人：陳奕廷

2022/10/4
Arbel R, Wolff Sagy Y, Hoshen M, Battat E, Lavie G, Sergienko R, et al.
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge.
N Engl J Med 2022; 387:790-798.
https://pubmed.ncbi.nlm.nih.gov/36001529/
報告人：何玉倩

2022/10/11
Wong CKH, Au ICH, Lau KTK, Lau EHY, Cowling BJ, Leung GM.
Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study.
Lancet Infect Dis 2022 Aug 24;S1473-3099(22)00507-2.
https://pubmed.ncbi.nlm.nih.gov/36029795/
報告人：江姿嫻

2022/10/12
Schwartz NG, Hernandez-Romieu AC, Annambhotla P, Filardo TD, Althomsons SP, Free RJ, et al.
Nationwide tuberculosis outbreak in the USA linked to a bone graft product: an outbreak report.
Lancet Infect Dis 2022 Nov;22(11):1617-1625.
https://pubmed.ncbi.nlm.nih.gov/35934016/
報告人：張傑翔

2022/10/18
Satlin MJ, Chen L, Gomez-Simmonds A, Marino J, Weston G, Bhowmick T, et al.
Impact of a Rapid Molecular Test for Klebsiella pneumoniae Carbapenemase and Ceftazidime-Avibactam Use on Outcomes After Bacteremia Caused by Carbapenem-Resistant Enterobacterales.
Clin Infect Dis 2022 May 6;ciac354.
https://pubmed.ncbi.nlm.nih.gov/35522019/
報告人：金婉

2022/10/19
Israelsen SB, Fally M, Tarp B, Kolte L, Ravn P, Benfield T.
Short-course antibiotic therapy for hospitalized patients with early clinical response in community-acquired pneumonia: a multicentre cohort study.
Clin Microbiol Infect 2022 Aug 19;S1198-743X(22)00420-7.
https://pubmed.ncbi.nlm.nih.gov/35988851/
報告人：林昱廷

2022/11/9
Patrier J, Villageois-Tran K, Szychowiak P, Ruckly S, Gschwind R, Wicky PH, et.al.
Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults.
Crit Care. 2022 Oct 3;26(1):300.
https://pubmed.ncbi.nlm.nih.gov/36192756/
報告人：劉芳綺

2022/11/15
Granillo A, Le Maréchal M, Diaz-Arias L, Probasco J, Venkatesan A, Hasbun R.
Development and Validation of a Risk Score to Differentiate Viral and Autoimmune Encephalitis in Adults.
Clin Infect Dis. 2022 Sep 2;ciac711.
https://pubmed.ncbi.nlm.nih.gov/36053949/
報告人：朱忠德

2022/11/16
Goto M, Hasegawa S, Balkenende EC, Clore GS, Safdar N, et al.
Effectiveness of Ultraviolet-C Disinfection on Hospital-Onset Gram-Negative Rod Bloodstream Infection: A Nationwide Stepped-Wedge Time-Series Analysis.
Clin Infect Dis. 2022 Sep 17;ciac776
https://pubmed.ncbi.nlm.nih.gov/36124706/
報告人：李柏陞

2022/11/22
Wildenthal JA, Atkinson A, Lewis S, Sayood S, Nolan NS, Cabrera NL, et.al
Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus Aureus Bacteremia in People Who Inject Drugs.
Clin Infect Dis. 2022 Sep 2;ciac714
https://pubmed.ncbi.nlm.nih.gov/36052413/
報告人：廖苑惠

2022/11/23
Grohs P, Vilfaillot A, Zahar JR, Barbut F, Frange P, Casetta A, et.al
Faecal carriage of multidrug-resistant bacteria and associated risk factors: results from a point prevalence study.
J Antimicrob Chemother . 2022 Sep 30;77(10):2667-2678.
https://pubmed.ncbi.nlm.nih.gov/36031727/
報告人：林彥廷

2022/11/28
Rocco JM, Laidlaw E, Galindo F, Anderson M, Rupert A, Higgins J, et al.
Severe Mycobacterial Immune Reconstitution Inflammatory Syndrome (IRIS) in Advanced Human Immunodeficiency Virus (HIV) Has Features of Hemophagocytic Lymphohistiocytosis and Requires Prolonged Immune Suppression.
Clin Infect Dis . 2022 Sep 1;ciac717.
https://pubmed.ncbi.nlm.nih.gov/36048425/
報告人：林妏霙

2022/12/6
Danneels P, Hamel JF, Picard L, Rezig S, Martinet P, Lorleac'h A, et.al
Impact of Enterococcus Faecalis Endocarditis Treatment on Risk of Relapse.
Clin Infect Dis. 2022 Sep 19;ciac777.
https://pubmed.ncbi.nlm.nih.gov/36124844/
報告人：賴冠璋

2022/12/13
Chi X, Meng X, Xiong L, Chen T, Zhou Y, Ji J, et al.
Small wards in the ICU: a favorable measure for controlling the transmission of carbapenem-resistant Klebsiella pneumoniae.
Intensive Care Med. 2022 Nov;48(11):1573-1581.
https://pubmed.ncbi.nlm.nih.gov/36129475/
報告人：郭泰輝

2022/12/14
Heinemann M, Kleinjohann L, Rolling T, Winter D, Hackbarth N, Ramharter M, Addo M, Eibach D, Phillips RO, Owusu-Ofori A, Vinnemeier CD.
Impact of antibiotic intake on incidence of extended spectrum beta-lactamase producing Enterobacterales in sub-Saharan Africa - results from a community-based longitudinal study.
Clin Microbiol Infect. 2022 Sep 20:S1198-743X(22)00476-1.
https://pubmed.ncbi.nlm.nih.gov/36150674/
報告人：林哲毅

2022/12/20
Moehring RW, Yarrington ME, Warren BG, Lokhnygina Y, Atkinson E, Bankston A, et al.
Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled Trial.
Clin Infect Dis. 2023 Feb 8;76(3):433-442.
https://pubmed.ncbi.nlm.nih.gov/36167851/
報告人：高士勛

2022/12/21
Escrihuela-Vidal F, Kaasch AJ, Von Cube M, Rieg S, Kern WV, Seifert H, et al.
Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort.
Clin Microbiol Infect. 2022 Oct 23:S1198-743X(22)00533-X.
https://pubmed.ncbi.nlm.nih.gov/36283610/
報告人：廖修誼